Philadelphia, PA, United States of America

Fabiana Zappala

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fabiana Zappala: Pioneering Innovations in Immunotherapy

Introduction: Fabiana Zappala, an inventive force located in Philadelphia, PA, is recognized for her contributions to the field of immunotherapy. With her patent for bispecific cytotoxic lymphocyte or macrophage-redirecting autoantibodies, Zappala is making waves in the medical community by addressing critical needs in treatment methods.

Latest Patents: Zappala holds a patent entitled "Bispecific cytotoxic lymphocyte or macrophage-redirecting autoantibodies, methods for production thereof and methods of treatment." This innovative patent focuses on a bispecific cytotoxic lymphocyte or macrophage-redirecting autoantibody that includes a cytotoxic lymphocyte or macrophage targeting domain, as well as an autoantibody. The methods described in the patent facilitate the production of these bispecific antibodies and outline their application in treating subjects in need by administering an isolated version of this groundbreaking therapy.

Career Highlights: Fabiana Zappala's career is marked by her role at the prestigious University of Pennsylvania. Here, she has been able to merge her academic knowledge with practical applications to push the boundaries of current medical treatments. Her research contributions are a testament to her dedication to advancing healthcare.

Collaborations: Zappala's work is not carried out in isolation; she collaborates with esteemed colleagues such as Andrew Tsourkas and James Z Hui. Their collective expertise enhances the research environment at the University of Pennsylvania, fostering innovation and leading to significant advancements in therapies that could change the lives of many patients.

Conclusion: Fabiana Zappala exemplifies the spirit of innovation in science and medicine. Her groundbreaking patent and collaborative efforts contribute to the evolving landscape of immunotherapy. As she continues her work at the University of Pennsylvania, her impact on the field promises to bring new hope to patients and set new standards in treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…